The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


APO-go® PFS 5mg/ml Solution for Infusion in Pre-filled Syringe*Abbreviated to APO-go in the text



Stada Arzneimittel AGPA0593/043/003

Main Information

Trade NameAPO-go® PFS 5mg/ml Solution for Infusion in Pre-filled Syringe*Abbreviated to APO-go in the text
Active SubstancesApomorphine hydrochloride
Dosage FormSolution for infusion in pre-filled syringe
Licence HolderStada Arzneimittel AG
Licence NumberPA0593/043/003

Group Information

ATC CodeN04BC Dopamine agonists
N04BC07 apomorphine

Status

License statusAuthorised
Licence Issued28/11/2014
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back